Would re-irradiation be an appropriate option? What dose/field would you incorporate? If treating with standard fractionation, would you take the enti...
New answer by Radiation Oncologist at Memorial Sloan Kettering Cancer Center (September 22, 2016)
Recurrent basal cell carcinoma can be challenging to manage. It is important recognize that vismodegib is FDA approved for basal cell carcinoma that is not treatable with sur...